Reaction Details |
| Report a problem with these data |
Target | Vasopressin V1b receptor |
---|
Ligand | BDBM50345056 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_749194 (CHEMBL1780922) |
---|
IC50 | 1±n/a nM |
---|
Citation | Napier, SE; Letourneau, JJ; Ansari, N; Auld, DS; Baker, J; Best, S; Campbell-Wan, L; Chan, R; Craighead, M; Desai, H; Ho, KK; MacSweeney, C; Milne, R; Richard Morphy, J; Neagu, I; Ohlmeyer, MH; Pick, J; Presland, J; Riviello, C; Zanetakos, HA; Zhao, J; Webb, ML Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists. Bioorg Med Chem Lett21:3813-7 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Vasopressin V1b receptor |
---|
Name: | Vasopressin V1b receptor |
Synonyms: | AVPR V1b | AVPR V3 | AVPR1B | AVPR3 | Antidiuretic hormone receptor 1b | V1BR_HUMAN | V1bR | VASOPRESSIN V1B | VPR3 | Vasopressin V1b receptor | Vasopressin V1b receptor (V1b) | Vasopressin V3 | Vasopressin V3 receptor |
Type: | Enzyme |
Mol. Mass.: | 46985.01 |
Organism: | Homo sapiens (Human) |
Description: | P47901 |
Residue: | 424 |
Sequence: | MDSGPLWDANPTPRGTLSAPNATTPWLGRDEELAKVEIGVLATVLVLATGGNLAVLLTLG
QLGRKRSRMHLFVLHLALTDLAVALFQVLPQLLWDITYRFQGPDLLCRAVKYLQVLSMFA
STYMLLAMTLDRYLAVCHPLRSLQQPGQSTYLLIAAPWLLAAIFSLPQVFIFSLREVIQG
SGVLDCWADFGFPWGPRAYLTWTTLAIFVLPVTMLTACYSLICHEICKNLKVKTQAWRVG
GGGWRTWDRPSPSTLAATTRGLPSRVSSINTISRAKIRTVKMTFVIVLAYIACWAPFFSV
QMWSVWDKNAPDEDSTNVAFTISMLLGNLNSCCNPWIYMGFNSHLLPRPLRHLACCGGPQ
PRMRRRLSDGSLSSRHTTLLTRSSCPATLSLSLSLTLSGRPRPEESPRDLELADGEGTAE
TIIF
|
|
|
BDBM50345056 |
---|
n/a |
---|
Name | BDBM50345056 |
Synonyms: | 2-(6-(3-((dimethylamino)methyl)phenyl)-2-(4-fluoro-3-methoxyphenyl)-4-oxoquinazolin-3(4H)-yl)-N-isopropylacetamide | CHEMBL1778961 |
Type | Small organic molecule |
Emp. Form. | C29H31FN4O3 |
Mol. Mass. | 502.5798 |
SMILES | COc1cc(ccc1F)-c1nc2ccc(cc2c(=O)n1CC(=O)NC(C)C)-c1cccc(CN(C)C)c1 |
Structure |
|